Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
8
×
Tags
biotech
8
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
8
×
san francisco blog main
clinical trials
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
fda
glaxosmithkline
sanofi
avexis
boston
bristol-myers squibb
cancer
cancer drugs
cancer immunotherapy
What
disease
8
×
drug
medicines
roundup
adds
bio
cancer
gene
hepatitis
known
liver
nash
new
news
race
research
according
address
advanced
ago
akcea
alliance
allosteric
alnylam’s
alzheimer's
approval
approved
areas
bad
bff
biosciences
biotech
bio’s
brain
brii
cancer’s
case
cases
caught
causing
Language
unset
Current search:
biotech
×
disease
×
photo
×
" national top stories "
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline